Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

AGM Statement

28 Apr 2005 07:00

Torex Retail PLC28 April 2005 Torex Retail Plc AGM Statement Torex Retail Plc ("Torex Retail" or "the Group"), the UK's market leader inretail IT solutions, will today hold its inaugural Annual General Meeting. RobLoosemore, Chairman, will comment on current trading as follows: "Torex Retail performed strongly in 2004 and the momentum developed during lastyear has been carried forward into 2005. We are pleased to report that tradingto date is in line with our expectations and, with buoyant market conditions anda high level of revenue visibility, the Board remain confident of both our fullyear forecasts and the future growth prospects for the Group. In addition, we are delighted with the progress made by the Alphameric RetailDivision (ARD), which was acquired in November 2004, and which continues totrade in line with our expectations. This reflects new business wins (AnnTaylor and Littlewoods) for our Smartdecision merchandise planning product,coupled with decisive action taken to reduce the cost base. The division is nowfully integrated into the Torex Retail business." Other highlights include: • First installations of Lucas into the UK: Following the successful launch in the UK of Lucas, our market leading Java EPOS solution, installations have already been completed with Esprit, Deichmann shoe stores and a major regional department store. Further announcements are expected shortly. • Cross selling of Lucas is ahead of schedule. The very strong demand for Lucas from the former ARD customer base has resulted in a number of early contract wins, including JD Sports with installations into their 68 UK stores planned for the next quarter. In addition, Lucas has already been installed in Reiss' flagship New York store and Nora O'Connell stores in Ireland. Chris Moore, Chief Executive, comments: "I am delighted with the start we have made to the year. Most encouraging hasbeen the new contract wins for Lucas, in particular, the deal with JD Sports inthe face of stiff competition. This win, together with the UK Lucas sales, willprovide valuable reference sites from which to leverage Lucas further into theUK market. The outlook for the full year remains very positive." It is expected that the Group's interim results for the six months ending 30June, 2005 will be announced in mid September 2005. Enquiries: Torex Retail 0870 050 9900 Rob Loosemoore, Chairman / Richard Thompson, FD Citigate Dewe Rogerson 020 7638 9571 Ginny Pulbrook / Sebastian Hoyle / Lucie Holloway This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jun 20217:00 amRNSCompletion of phase 1 of new US facility expansion
23rd Jun 20216:08 pmRNSDirector/PDMR Shareholding
10th Jun 20214:17 pmRNSHolding(s) in Company
3rd Jun 20211:37 pmRNSResult of AGM
11th May 20217:00 amRNSDirector/PDMR Shareholding
10th May 202110:00 amRNSDirector/PDMR Shareholding
5th May 20217:00 amRNSGrant of share options
29th Apr 20214:11 pmRNSHolding(s) in Company
28th Apr 20217:00 amRNSFinal Results and Notice of AGM
20th Apr 20211:07 pmRNSHolding(s) in Company
20th Apr 202112:10 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSNotice of Results
13th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:40 pmRNSSecond Price Monitoring Extn
1st Apr 20214:36 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSInitial phase of US facility expansion complete
26th Feb 20217:00 amRNSDirectorate Change
19th Feb 20213:52 pmRNSHolding(s) in Company
11th Feb 20217:00 amRNSMove to Electronic Reporting
8th Feb 20217:00 amRNSTrading Update
5th Feb 20214:40 pmRNSSecond Price Monitoring Extn
5th Feb 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSAppointment of Chief Financial Officer
6th Jan 20213:58 pmRNSPDMR Dealings
5th Jan 20217:00 amRNSConfirmation of Board appointments
4th Jan 202111:26 amRNSHoldings in Company
24th Dec 202012:56 pmRNSIssue of Equity & Total Voting Rights Replacement
24th Dec 202011:15 amRNSHoldings in Company
23rd Dec 20209:51 amRNSIssue of Equity and Total Voting Rights
4th Dec 20207:00 amRNSBoard Changes
3rd Dec 20204:54 pmRNSHoldings in Company
2nd Dec 20207:00 amRNSFirst delivery of OrthoPure® XT
27th Nov 20209:09 amRNSHoldings in Company
26th Nov 20204:02 pmRNSHoldings in Company
17th Nov 20207:00 amRNSAppointment of CEO
6th Nov 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSHoldings in Company
29th Oct 20207:00 amRNSChange of Registered Office
26th Oct 20204:50 pmRNSHoldings in Company
7th Oct 20201:50 pmEQSHardman & Co Research: Tissue Regenix (TRX): Funded through to profitability
28th Sep 202012:24 pmRNSHoldings in Company
16th Sep 20207:42 amRNSHoldings in Company
15th Sep 20204:40 pmRNSSecond Price Monitoring Extn
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20205:33 pmRNSHoldings in Company
2nd Sep 20207:00 amRNSUnaudited Interim Results
27th Aug 20207:00 amRNSNotice of Interim Results & Investor Presentation
24th Aug 20207:00 amRNSUK distribution partner for OrthoPure® XT
18th Aug 202011:27 amRNSHoldings in Company
17th Aug 20207:00 amRNSRelocation of UK office and manufacturing facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.